chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: FLUX
Symptoms: Bronchitis, Influenza
Clinical narrative: got Flu now; gone into Bronchitis; Initial information received on 31-Dec-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who got flu now and gone into bronchitis after receiving Influenza Vaccine.  The patient's past medical history included COVID-19 and Pneumonia last year (2021), patient was hospitalized for pneumonia for by days and got COVID when got home The patient's past vaccination(s) included COVID-19 VACCINE. in 2021 The patient's past medical treatment(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect Influenza Vaccine produced by unknown manufacturer lot number not reported via unknown route with unknown form, strength, frequency, route, expiry date for Immunisation.  On an unknown date the patient had got flu now (influenza) and gone into bronchitis (bronchitis) (unknown latency) after the administration of Influenza Vaccine.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (gone into Bronchitis, got Flu now).  Outcome: Unknown for the event bronchitis and was Not Recovered / Not Resolved for the event influenza.  Seriousness criteria: medically significant for event influenza.; Sender's Comments: Sanofi company comment dated 04-Jan-2023: This case concerns a patient who has received Influenza Vaccine and experienced influenza and bronchitis. There is no evidence to suggest a causal role of the suspect product hence the event has been assessed as unrelated to the product. There is no pharmacological plausibility of the patient to develop influenza and bronchitis after receiving Influenza Vaccine, hence the benefit risk profile of product is not affected by this report.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Malaise
Clinical narrative: sick with the flu; Initial information received on 31-Dec-2022 regarding an unsolicited valid Social Media non-serious case received via consumer.  This case involves an unknown age and unknown gender patient who got sick with the flu after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor    On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer (dose, strength, frequency, formulation, batch number, expiry date: unknown) via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the patient diagnosed with a non-serious sick with the flu (influenza) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available  Action taken was not applicable.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was Unknown.
Age: 79.0
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: Got his/her flu shot Oct. 1 and now have the flu anyway; Initial information received on 02-Jan-2023 regarding an unsolicited valid social media non-serious case received from a consumer/non-healthcare professional (hcp).  This case involves a 79-year-old and unknown gender patient who got his/her flu shot oct. 1 and now have the flu anyway after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On October 1, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, route, dose: unknown) (lot number and expiry date: not reported) in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date, the patient developed a non-serious event of got his/her flu shot and now have the flu anyway (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events. It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available.   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown.
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome
Clinical narrative: Guillain-Barré syndrome; This spontaneous case from was received on 29-Dec-2022 from a physician via Agency (reference number: SEQW22-06722), and concerned an adult, male patient. At the time of initial reporting, the patient was 68-year-old.  The patient's medical history and concomitant medications were not reported.  On an unspecified date in Dec-2014 (also discrepantly reported as 'Dec-2016'), the patient was vaccinated with influenza vaccine (brand not specified; dose, anatomical location, and route of administration: not reported) for influenza prophylaxis. The batch number was not reported.  On an unspecified date in May-2015, six months after receiving influenza vaccine, the patient experienced Guillain-Barré syndrome (GBS).  On an unspecified date in May-2015, the patient was admitted to hospital for treatment of GBS.   On an unspecified date in May-2015, the patient recovered from the event. Since then, in seven years, on recommendation, the patient had never had a flu shot again, and had not suffered anything like GBS, as reported.  On an unspecified date, the patient was discharged from hospital.  On an unspecified date in 2021, the patient was vaccinated with COVID-19 vaccine (brand not specified), and was fine, nothing like GBS happened.  At the time of initial reporting on 29-Dec-2022, the patient reported comorbidities like hypertension and obesity and wanted to know if it is safe for him to start immunization against Influenza again and if flu vaccine has any contraindications in people with a previous history of GBS.  The reporter assessed the event of Guillain-Barré syndrome to be not related to influenza vaccine. The reporter did not think the GBS was related to the flu shot because the event happened only six months after the vaccination.   The event of Guillain-Barré syndrome was assessed as serious due to the seriousness criterion of hospitalization, and additionally was considered to be medically significant by a Physician within Seqirus's Pharmacovigilance and Risk Management Department.  Company Comment: An adult, male patient was vaccinated with influenza vaccine. Six months after vaccination, the patient experienced Guillain-Barré syndrome. Information regarding clinical course, relevant diagnostic findings and corrective treatment was not provided. Causal role of the suspect vaccine is assessed as not related for the event Guillain Barre syndrome, due to chronological implausibility. Agency criteria for the event Guillain Barre syndrome could not be assessed due to insufficient information.; Sender's Comments: An adult, male patient was vaccinated with influenza vaccine. Six months after vaccination, the patient experienced Guillain-Barré syndrome. Information regarding clinical course, relevant diagnostic findings and corrective treatment was not provided. Causal role of the suspect vaccine is assessed as not related for the event Guillain Barre syndrome, due to chronological implausibility. Agency criteria for the event Guillain Barre syndrome could not be assessed due to insufficient information.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had shingles after the vaccine/Suspected vaccination failure; Shingles (thought it was impetigo); This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 30-DEC-2022 Reporter's Comment: This case was reported by a patient via  interactive digital media. The patient received a dose of Shingles vaccine and had shingles even after the vaccine, but because there was virtually no pain, the patient did not know what they were. The patient thought he/she had picked up impetigo from one of the grands.  The patient's doctor said the vaccine kept it from being so bad. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding, primary schedule, laboratory test and time to onset confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: GOT COVID; This spontaneous report received from a patient via a company representative concerned a 72 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. Age at time of vaccination 8 decade old. The batch number was not reported. Per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On SEP-2022, the patient experienced got covid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got covid was not reported. This report was non-serious. This report was associated with a product quality complaint:
Age: 1.58
Sex: F
Vaccine: COVID19-2
Symptoms: Rash
Clinical narrative: rash on the abdomen and chest; This spontaneous case was reported by a physician and describes the occurrence of RASH (rash on the abdomen and chest) in an infant female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine on 24-Jun-2022 and Moderna COVID-19 Vaccine on 29-Jul-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine.    On 02-Jan-2023 at 5:03 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash on the abdomen and chest). At the time of the report, RASH (rash on the abdomen and chest) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The parent reported a rash on the abdomen and chest starting 4 hours after the vaccine administration.  Concomitant medication was not provided. Treatment medication information was not provided by the reporter.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022) and NO ADVERSE EVENT (no adverse event) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022).    Concomitant medications were not reported.                                       No treatment information was provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Discomfort
Clinical narrative: discomfort with the first and second shot, a tiny discomfort with the first booster shot; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (discomfort with the first and second shot, a tiny discomfort with the first booster shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.   On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (discomfort with the first and second shot, a tiny discomfort with the first booster shot). At the time of the report, DISCOMFORT (discomfort with the first and second shot, a tiny discomfort with the first booster shot) outcome was unknown.            Concomitant medication was not reported.  It was reported the patient had a little discomfort with the first and second shot, a tiny discomfort with the first booster shot.  Treatment drug was not reported.   This case was linked to MODERNATX, INC.-MOD-2023-694105 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2023-694105:Bivalent dose
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain
Clinical narrative: Lingering achiness; Brain fog feelings with the second bivalent booster; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Lingering achiness) and FEELING ABNORMAL (Brain fog feelings with the second bivalent booster) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Lingering achiness) and FEELING ABNORMAL (Brain fog feelings with the second bivalent booster). At the time of the report, PAIN (Lingering achiness) and FEELING ABNORMAL (Brain fog feelings with the second bivalent booster) outcome was unknown.            Concomitant medication was not provided. Treatment medication information was not provided by the reporter.   This case was linked to MOD-2023-694104 (Patient Link).
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; 3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old) and NO ADVERSE EVENT (No adverse event) in a 3-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Dec-2022, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old).    No concomitant medications were reported.   No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jan-2023: Follow-up document included no new information.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Loss of personal independence in daily activities, Pain in extremity, Skin ulcer, Vaccination failure
Clinical narrative: Had Vx years ago, then shingles/suspected vaccination failure; shingles/just got shingles; sores on back, stomach, legs, have dressings changed; my legs are so sore, have dressings changed; been out of work for 4 months; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, skin ulcer, leg pain and activities of daily living impaired. On an unknown date, the outcome of the vaccination failure, shingles, skin ulcer and leg pain were unknown and the outcome of the activities of daily living impaired was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, skin ulcer, leg pain and activities of daily living impaired to be related to Shingles vaccine.     Additional Information: GSK receipt date: 29-Dec-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the shingles vaccine a couple years ago from reporting and just got shingles. The patient had been out of work for 4 months. The patient did not thought that's right, he/she had got sores on his/her back sores, sores on stomach and legs were so sore. The patient had to have dressings changed on them every day. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; patient received the bivalent dose of Moderna COVID19 vaccine as a first dose in another facility; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient received the bivalent dose of Moderna COVID19 vaccine as a first dose in another facility) and NO ADVERSE EVENT (No adverse event) in an 18-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 013h22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Nov-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Nov-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (patient received the bivalent dose of Moderna COVID19 vaccine as a first dose in another facility). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient received the bivalent dose of Moderna COVID19 vaccine as a first dose in another facility) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient received the bivalent dose of Moderna COVID19 vaccine as a first dose in another facility).    No concomitant medication was provided by reporter.  it was reported HCP wanted to know what to do next Patient wanted to receive the second dose of the primary series and looking at the patient's records HCP realized that the patient received the bivalent dose of Moderna COVID19 vaccine as a first dose in another facility, date of administration Nov15 2022.  No treatment medication was provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In October 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2022, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient stated she had received 2 doses of the Moderna COVID-19 vaccine and 2 boosters. No treatment medications were reported.
Sex: M
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: took the flu shot and has the flu now; Initial information received on 03-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age male patient who took the flu shot and has the flu now.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a Unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, Strength, formulation, Expiry date was not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient took the flu shot and has the flu now (influenza) (unknown latency).  It is unknown if there were lab data/results available.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Sex: U
Vaccine: IPV
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: Previous excursion on the same products in June 2020 at a high of 49.8F for 2 hours with no adverse event; IPOL MDV is opened and one patient has been administered a dose since the excursion in June 2020.; Initial information received on 03-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient of an unknown age and gender who had administered a dose of IPV (VERO) [IPOL] since the excursion in june 2020 and previous excursion on the same products in june 2020 at a high of 49.8F for 2 hours with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received of suspect IPV (VERO) for suspension for injection (lot VIA024M, dose, formulation, strength, expiry date: unknown) via unknown route in unknown administration site for immunization and ipol mdv opened and one patient has been administered a dose since the excursion in june 2020 (poor quality product administered), previous excursion on the same products in june 2020 at a high of 49.8f for 2 hours with no adverse event (product storage error) (unknown latency).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test abnormal, Cardiomegaly, Chest X-ray abnormal, Chest pain
Clinical narrative: Second dose of COVID 19 vaccine Pfizer 301458A allergic reaction. Injection site hot to the touch, itchy, inflammation and red. Felt weak for a couple of days. I been having chest pain for a couple of months now after the injection and was referred to cardiologist. I had no issue before the vaccine with my heart. I have three abnormal EKGs, X-ray showing slightly enlarged heart, blood work with elevated levels. I am scheduled to do an ECO exam and stress test.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Hypersensitivity, Injection site erythema, Injection site inflammation, Injection site pruritus
Clinical narrative: Second dose of COVID 19 vaccine Pfizer 301458A allergic reaction. Injection site hot to the touch, itchy, inflammation and red. Felt weak for a couple of days. I been having chest pain for a couple of months now after the injection and was referred to cardiologist. I had no issue before the vaccine with my heart. I have three abnormal EKGs, X-ray showing slightly enlarged heart, blood work with elevated levels. I am scheduled to do an ECO exam and stress test.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth
Clinical narrative: Second dose of COVID 19 vaccine Pfizer 301458A allergic reaction. Injection site hot to the touch, itchy, inflammation and red. Felt weak for a couple of days. I been having chest pain for a couple of months now after the injection and was referred to cardiologist. I had no issue before the vaccine with my heart. I have three abnormal EKGs, X-ray showing slightly enlarged heart, blood work with elevated levels. I am scheduled to do an ECO exam and stress test.
Sex: U
Vaccine: FLUX
Symptoms: Mobility decreased
Clinical narrative: Sept 2022 ER visit, presented as inability to move right arm. Believed to be AE from flu vaccine earlier that week, noted.
Age: 29.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lymphadenopathy
Clinical narrative: Systemic: Lymph Node Swelling-Medium
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Axillary pain, Chills, Fatigue, Headache, Lethargy
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: paint in the armpit of same arm that was injected-Medium, Systemic: Headache-Medium
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: paint in the armpit of same arm that was injected-Medium, Systemic: Headache-Medium
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Rash, Vomiting
Clinical narrative: Facial rash
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Lacrimation increased, Rhinorrhoea, SARS-CoV-2 test negative, Sneezing
Clinical narrative: 12/26/22 I started sneezing, had a runny nose, itchy and runny eyes, and a cough. At first I thought it was allergies, but this seemed different from allergies. The next day, I had the same symptoms, the runny nose was worse. I went to a COVID testing site to take a COVID test.   Both the rapid and PCR tests were negative.  I figured it was a viral infection. My symptoms did not worsen, and I felt better within a few days. I figured it was just some type of virus.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 2/10/21, 3/17/21, 11/3/21. Positive on 1/5/23
Age: 74.0
Sex: F
Vaccine: FLU4
Symptoms: Exercise tolerance decreased, Injection site pain
Clinical narrative: I received the high dose vax in my left arm. A couple of days after the injection my arm in that area became sore. The soreness was intermittent and came and went. I still have the soreness but it's not that sore as it was. It seems to come in on that area after exercising and inclement weather.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Janssen 3/9/21, Moderna 11/1/21, 4/1/22, Pfizer 9/15/22. Positive on 1/4/23
Age: 1.25
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Influenza virus test negative, Pyrexia
Clinical narrative: Entire household had COVID-19 on 12/22/2022. She had fever for one day with a high of 103 and minor cough/congestion. Was much better the next day with mild congestion and persistent cough.  Did not take her into PCP at this time because she was improving and they require a COVID-19 test to be seen. 12/27 took  her to an urgent clinic because cough was not improving. Urgent clinic tested her for COVID-19 and she was positive. Was instructed to treat symptoms and monitor her condition. Was instructed to return in 3 days if not improving
Age: 1.25
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Entire household had COVID-19 on 12/22/2022. She had fever for one day with a high of 103 and minor cough/congestion. Was much better the next day with mild congestion and persistent cough.  Did not take her into PCP at this time because she was improving and they require a COVID-19 test to be seen. 12/27 took  her to an urgent clinic because cough was not improving. Urgent clinic tested her for COVID-19 and she was positive. Was instructed to treat symptoms and monitor her condition. Was instructed to return in 3 days if not improving
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 3/1/21, 3/29/21. Positive on 1/4/23
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Cough, Decreased appetite, Malaise
Clinical narrative: I woke up feeling horrible, I had really bad coughing, fatigue, lack of taste, and a runny nose. I also lost my appetite. I tested a few days later at a clinic and was positive for COVID-19. The PA the Tessalon Pearls and this did help with the cough. This was the only medication I could be given since I am on a blood thinner. This entire ordeal lasted for about three weeks.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I woke up feeling horrible, I had really bad coughing, fatigue, lack of taste, and a runny nose. I also lost my appetite. I tested a few days later at a clinic and was positive for COVID-19. The PA the Tessalon Pearls and this did help with the cough. This was the only medication I could be given since I am on a blood thinner. This entire ordeal lasted for about three weeks.
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization with unrelated diagnosis, tested prior to transfer to transitional care unit, patient is asymptomatic.
Age: 68.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Cough, Influenza virus test negative, Malaise, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: I had post nasal drip, clogged head, cough, chest congestion, feeling horrible all over, sore throat. I was prescribed 4 days z-pack. I get this every fall.
Age: 68.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: SARS-CoV-2 test negative, Upper-airway cough syndrome
Clinical narrative: I had post nasal drip, clogged head, cough, chest congestion, feeling horrible all over, sore throat. I was prescribed 4 days z-pack. I get this every fall.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dry throat, Neck pain, Oropharyngeal pain, Pain, Pain in jaw
Clinical narrative: Around 07:15AM ET  on 0/04/2023 I woke up with a dry throat and made tea to help but my throat become so sore I went to urgent care around 2PM ET that afternoon it felt like needle in my throat and my neck under my jaw began to hurt and it was throbbing . I had no fatigue or other symptoms just the pain.  At Urgent Care a Strep and COVID-19 tests were performed both tests were negative. At an inspection of my throat I was diagnosed with tonsillitis.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test negative, Streptococcus test negative, Tonsillitis
Clinical narrative: Around 07:15AM ET  on 0/04/2023 I woke up with a dry throat and made tea to help but my throat become so sore I went to urgent care around 2PM ET that afternoon it felt like needle in my throat and my neck under my jaw began to hurt and it was throbbing . I had no fatigue or other symptoms just the pain.  At Urgent Care a Strep and COVID-19 tests were performed both tests were negative. At an inspection of my throat I was diagnosed with tonsillitis.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal discomfort, COVID-19, Cough, Injection site pain, Malaise
Clinical narrative: I had soreness at the injection site for two days. On 12/01/2022, I started not feeling well with a cough, upper respiratory issues and gastro issues. On 12/02/2022, I tested positive for COVID-19 with a home test. I had a telehealth visit with a provider on 12/03/2022 and got a prescription for Paxlovid. On day two of taking Paxlovid I was feeling better. I rebound the following week as I was warned.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory symptom, SARS-CoV-2 test positive
Clinical narrative: I had soreness at the injection site for two days. On 12/01/2022, I started not feeling well with a cough, upper respiratory issues and gastro issues. On 12/02/2022, I tested positive for COVID-19 with a home test. I had a telehealth visit with a provider on 12/03/2022 and got a prescription for Paxlovid. On day two of taking Paxlovid I was feeling better. I rebound the following week as I was warned.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Asthenia, Atrial fibrillation, Benign prostatic hyperplasia, COVID-19
Clinical narrative: Patient is a 79 y.o. male patient of DO with history of hypertension, chronic A. fib on anticoagulation, CAD, dyslipidemia presented to Hospital with generalized weakness, cough and shortness of breath admitted for COVID-19 Clinical Summary   Covid-19 Virus Infection Date of onset of symptoms: 2 days PTA Symptoms present on admission: DOE Date of covid positive test: 12/19 Vaccination status: vaccinated Imaging: CXR Oxygen requirements on admission: 2 lit Current oxygen requirements: 2 lit Medical therapy: steroids Consultants following: None Anticipated special isolation end date: 12/29  - Supplemental oxygen requirement resolved   Weakness Secondary to COVID PT and OT consult   Paroxysmal afib In NSR. On amio and cont on Eliquis   HTN Cont on Lisinopril and Toprol   Diabetes type-2 Hold Metformin, add SSI   BPH Cont on flomax   Dyslipidemia Cont on Statin
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray, Cough, Dyspnoea, SARS-CoV-2 test positive, Type 2 diabetes mellitus
Clinical narrative: Patient is a 79 y.o. male patient of DO with history of hypertension, chronic A. fib on anticoagulation, CAD, dyslipidemia presented to Hospital with generalized weakness, cough and shortness of breath admitted for COVID-19 Clinical Summary   Covid-19 Virus Infection Date of onset of symptoms: 2 days PTA Symptoms present on admission: DOE Date of covid positive test: 12/19 Vaccination status: vaccinated Imaging: CXR Oxygen requirements on admission: 2 lit Current oxygen requirements: 2 lit Medical therapy: steroids Consultants following: None Anticipated special isolation end date: 12/29  - Supplemental oxygen requirement resolved   Weakness Secondary to COVID PT and OT consult   Paroxysmal afib In NSR. On amio and cont on Eliquis   HTN Cont on Lisinopril and Toprol   Diabetes type-2 Hold Metformin, add SSI   BPH Cont on flomax   Dyslipidemia Cont on Statin
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Had given patient second COVID vaccine with consent. Patient tolerated well. I was notified on 10-31-22 that the vaccine was actually expired when I had given to patient, per Pfizer it was a short dated vaccine. I notified patient's guardian of incident, guardian was understanding of situation and verbalized understanding.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Adhesiolysis, Angiogram, Asthenia, COVID-19
Clinical narrative: COVID+ 12/28/22.  Vaccination status - J&J x1 Discharge Summary  SHMG HOSPITALIST                                              Discharge Information: Discharge Provider: MD  Primary Care Provider : DO  Procedures to be scheduled by PCP: None Results/Procedures requiring PCP followup: None Admission Date: 12/28/2022 Discharge Date: 01/03/2023 Admitting Diagnoses: COVID-19 Details of Hospital Stay PRESENTING PROBLEM:  Hypokalemia  Lightheadedness  Generalized weakness AKI (acute kidney injury) (HCC)  COVID  COVID-19    HOSPITAL COURSE: Patient is a 66-year-old female with multiple medical problems including urostomy, and colostomy.  She also has a history of PEs in the past but is not currently on anticoagulation.  She has had 3 weeks of intermittent dizziness usually whenever she stands with a feeling like she is going to pass out. She has apparently only passed out once and it was yesterday briefly.  She has had no loss of consciousness today.  Her only activity has been going to the bathroom, and returning immediately to her chair.  This has been going on for at least 3 weeks.  She has apparently started a workup with her primary care physician which included a stress test, and a CT angiogram thorax to re-evaluate for further PE.  She denies fevers however, her son at the bedside notes that she has had a pretty significant cough the last week or so.  She reports that she has not had any further increase in output of her colostomy until today and now she has had a lot of output more than usual, consistent with diarrhea.  She denies blood in the stool.   she initially reported that she has been eating and drinking adequately, however her son at the bedside disagrees and when pressed she agrees that her intake has been poor.  Son at the bedside also reports that he was up visiting for the holidays and when he came in the house yesterday she appeared so ill that he told her he was going to bring her to the hospital today.  She was admitted and we struggled with hyponatremia and hypomagnesemia.  We also worked to try and slow down the output from her colostomy.  We added Questran and Lomotil with some success.  She stabilized and we overshot the potassium and she actually had to have some reduction so we held her potassium supplementation treated with Lokelma.  Enteric pathogens and C difficile were negative.  Discussed at length the need for controlling her colostomy output.  Her renal function stabilized, potassium levels normalized.  Her respiratory status was stable and she was at her functional baseline.  It was felt she could return home with continued outpatient care.  She was discharged in stable condition./
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac stress test, Clostridium test negative, Colectomy, Colostomy, Cystoscopy
Clinical narrative: COVID+ 12/28/22.  Vaccination status - J&J x1 Discharge Summary  SHMG HOSPITALIST                                              Discharge Information: Discharge Provider: MD  Primary Care Provider : DO  Procedures to be scheduled by PCP: None Results/Procedures requiring PCP followup: None Admission Date: 12/28/2022 Discharge Date: 01/03/2023 Admitting Diagnoses: COVID-19 Details of Hospital Stay PRESENTING PROBLEM:  Hypokalemia  Lightheadedness  Generalized weakness AKI (acute kidney injury) (HCC)  COVID  COVID-19    HOSPITAL COURSE: Patient is a 66-year-old female with multiple medical problems including urostomy, and colostomy.  She also has a history of PEs in the past but is not currently on anticoagulation.  She has had 3 weeks of intermittent dizziness usually whenever she stands with a feeling like she is going to pass out. She has apparently only passed out once and it was yesterday briefly.  She has had no loss of consciousness today.  Her only activity has been going to the bathroom, and returning immediately to her chair.  This has been going on for at least 3 weeks.  She has apparently started a workup with her primary care physician which included a stress test, and a CT angiogram thorax to re-evaluate for further PE.  She denies fevers however, her son at the bedside notes that she has had a pretty significant cough the last week or so.  She reports that she has not had any further increase in output of her colostomy until today and now she has had a lot of output more than usual, consistent with diarrhea.  She denies blood in the stool.   she initially reported that she has been eating and drinking adequately, however her son at the bedside disagrees and when pressed she agrees that her intake has been poor.  Son at the bedside also reports that he was up visiting for the holidays and when he came in the house yesterday she appeared so ill that he told her he was going to bring her to the hospital today.  She was admitted and we struggled with hyponatremia and hypomagnesemia.  We also worked to try and slow down the output from her colostomy.  We added Questran and Lomotil with some success.  She stabilized and we overshot the potassium and she actually had to have some reduction so we held her potassium supplementation treated with Lokelma.  Enteric pathogens and C difficile were negative.  Discussed at length the need for controlling her colostomy output.  Her renal function stabilized, potassium levels normalized.  Her respiratory status was stable and she was at her functional baseline.  It was felt she could return home with continued outpatient care.  She was discharged in stable condition./
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Dizziness postural, Electrolyte substitution therapy, Explorative laparotomy
Clinical narrative: COVID+ 12/28/22.  Vaccination status - J&J x1 Discharge Summary  SHMG HOSPITALIST                                              Discharge Information: Discharge Provider: MD  Primary Care Provider : DO  Procedures to be scheduled by PCP: None Results/Procedures requiring PCP followup: None Admission Date: 12/28/2022 Discharge Date: 01/03/2023 Admitting Diagnoses: COVID-19 Details of Hospital Stay PRESENTING PROBLEM:  Hypokalemia  Lightheadedness  Generalized weakness AKI (acute kidney injury) (HCC)  COVID  COVID-19    HOSPITAL COURSE: Patient is a 66-year-old female with multiple medical problems including urostomy, and colostomy.  She also has a history of PEs in the past but is not currently on anticoagulation.  She has had 3 weeks of intermittent dizziness usually whenever she stands with a feeling like she is going to pass out. She has apparently only passed out once and it was yesterday briefly.  She has had no loss of consciousness today.  Her only activity has been going to the bathroom, and returning immediately to her chair.  This has been going on for at least 3 weeks.  She has apparently started a workup with her primary care physician which included a stress test, and a CT angiogram thorax to re-evaluate for further PE.  She denies fevers however, her son at the bedside notes that she has had a pretty significant cough the last week or so.  She reports that she has not had any further increase in output of her colostomy until today and now she has had a lot of output more than usual, consistent with diarrhea.  She denies blood in the stool.   she initially reported that she has been eating and drinking adequately, however her son at the bedside disagrees and when pressed she agrees that her intake has been poor.  Son at the bedside also reports that he was up visiting for the holidays and when he came in the house yesterday she appeared so ill that he told her he was going to bring her to the hospital today.  She was admitted and we struggled with hyponatremia and hypomagnesemia.  We also worked to try and slow down the output from her colostomy.  We added Questran and Lomotil with some success.  She stabilized and we overshot the potassium and she actually had to have some reduction so we held her potassium supplementation treated with Lokelma.  Enteric pathogens and C difficile were negative.  Discussed at length the need for controlling her colostomy output.  Her renal function stabilized, potassium levels normalized.  Her respiratory status was stable and she was at her functional baseline.  It was felt she could return home with continued outpatient care.  She was discharged in stable condition./